A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo | MicrobiomeTrials← Back to trialsNCT07431177
A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-03-09Est. Completion: 2028-06-06
Enrollment target: 210 participants Locations- Cahaba Derm and skin hlth ctr 27, Birmingham, Alabama, United States
- First OC Dermatology, Fountain Valley, California, United States
- MedDerm Associates, San Diego, California, United States
- Clinical Trials Research Institute, Thousand Oaks, California, United States
- Encore Medical Research, Hollywood, Florida, United States
- Mayo Clinic Jacksonville, Jacksonville, Florida, United States
- Miami Derm and Laser Institute, Miami, Florida, United States
- Global Clinical Professionals, St. Petersburg, Florida, United States
- Dawes Fretzin Clinical Rea Group, Indianapolis, Indiana, United States
- Hamzavi Dermatology, Fort Gratiot, Michigan, United States
- Revival Research Institute, Troy, Michigan, United States
- Skin Specialists PC, Omaha, Nebraska, United States
- Las Vegas Dermatology, Las Vegas, Nevada, United States
- Equity Medical, The Bronx, New York, United States
- Oregon Medical Research Center, Portland, Oregon, United States
- International Clinical Research Tennessee LCC, Murfreesboro, Tennessee, United States
Other microbiome trials you might be interested in
VitiligoNon-Segmental Vitiligo (NSV)
The purpose of this study is to evaluate how well LY4005130 is tolerated and what side effects may occur in participants…
Phoenix, United StatesEst. completion May 2027
Non-Segmental Vitiligo (NSV)
This study is a prospective, multicenter, real-world observational study to assess the clinical efficacy and safety of t…
Shenzhen, ChinaEst. completion Dec 2026
Bellaire Dermatology Associates, Bellaire, Texas, United StatesCenter for Clinical Studies, Houston, Texas, United StatesAustin Inst for Clinical Research, Pflugerville, Texas, United StatesACRC Trials, Plano, Texas, United StatesVirginia Clinical Research, Norfolk, Virginia, United StatesNovartis Investigative Site, Buenos Aires, Buenos Aires, ArgentinaNovartis Investigative Site, Caba, Buenos Aires, ArgentinaNovartis Investigative Site, Rosario, Santa Fe Province, ArgentinaNovartis Investigative Site, Sydney, New South Wales, AustraliaNovartis Investigative Site, Waitara, New South Wales, AustraliaNovartis Investigative Site, Melbourne, Victoria, AustraliaNovartis Investigative Site, Calgary, Alberta, CanadaNovartis Investigative Site, Winnipeg, Manitoba, CanadaNovartis Investigative Site, Mississauga, Ontario, CanadaNovartis Investigative Site, Newmarket, Ontario, CanadaNovartis Investigative Site, Toronto, Ontario, CanadaNovartis Investigative Site, Québec, Quebec, CanadaNovartis Investigative Site, Guangzhou, Guangdong, ChinaNovartis Investigative Site, Wuhan, Hubei, ChinaNovartis Investigative Site, Beijing, ChinaNovartis Investigative Site, Shanghai, ChinaNovartis Investigative Site, Bordeaux, FranceNovartis Investigative Site, Brest, FranceNovartis Investigative Site, Créteil, FranceNovartis Investigative Site, Nice, FranceNovartis Investigative Site, Reims, FranceNovartis Investigative Site, Rouen, FranceNovartis Investigative Site, Toulouse, FranceNovartis Investigative Site, Munich, Bavaria, GermanyNovartis Investigative Site, Bad Bentheim, GermanyNovartis Investigative Site, Bielefeld, GermanyNovartis Investigative Site, Hamburg, GermanyNovartis Investigative Site, Hanover, GermanyNovartis Investigative Site, Lübeck, GermanyNovartis Investigative Site, Münster, GermanyNovartis Investigative Site, Tübingen, GermanyNovartis Investigative Site, Ahmedabad, Gujarat, IndiaNovartis Investigative Site, Bangalore, Karnataka, IndiaNovartis Investigative Site, Belagavi, Karnataka, IndiaNovartis Investigative Site, Mysore, Karnataka, IndiaNovartis Investigative Site, Nashik, Maharashtra, IndiaNovartis Investigative Site, Ancona, AN, ItalyNovartis Investigative Site, Cona, FE, ItalyNovartis Investigative Site, Milan, MI, ItalyNovartis Investigative Site, Rozzano, MI, ItalyNovartis Investigative Site, Nagoya, Aichi-ken, JapanNovartis Investigative Site, Nagoya, Aichi-ken, JapanNovartis Investigative Site, Urayasu, Chiba, JapanNovartis Investigative Site, Shinjuku Ku, Tokyo, JapanNovartis Investigative Site, Kofu, Yamanashi, JapanNovartis Investigative Site, Niigata, JapanNovartis Investigative Site, Amsterdam, North Holland, NetherlandsNovartis Investigative Site, Rotterdam, South Holland, NetherlandsNovartis Investigative Site, Santiago de Compostela, A Coruna, SpainNovartis Investigative Site, Barcelona, SpainNovartis Investigative Site, Córdoba, SpainNovartis Investigative Site, Madrid, SpainNovartis Investigative Site, Madrid, SpainNovartis Investigative Site, Pontevedra, SpainNovartis Investigative Site, Seville, Spain